STING1 and neoplasm: Furthermore, CS/MTO-Cu@AMI enhances anti-tumor immunity by stimulating the cGAS-STING pathway, which plays a critical role in promoting immune surveillance and response against tumors, making it a promising candidate for combination therapies targeting immune checkpoints (Tian et al., 2023).